SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

The World Cup warning: Riots don’t start in the streets. They start online

“There’s a price where you have to say yes”: CyberArk founder on the $25 billion Palo Alto deal

"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"

“There is no better solution for Zim than the one we created”

Buzz

Most popular

Daily

Weekly

1

"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"

2

Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat

3

"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"

4

Echo: “Employees have become very good at identifying performative culture”

5

Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR

Life Sciences

5 stories about Life Sciences

העימותים ו מהומות ב הפגנות ב רצועת עזה גדר

CTech’s Monday Roundup of Israeli Tech News

Former Google CEO Eric Schmidt to visit Israel. U.S. Treasury Secretary Mnuchin discusses tax reform with Israeli counterpart. Report says Israel’s life sciences industry is dominated by small scale startups

בריאות דיגיטלית מדעי החיים רפואה טיפול 1

Israel’s Life Sciences Industry Is Dominated by Small Scale Startups

14.05.18|Lilach Baumer

65% of all Israel-based life sciences companies employ 10 people or less, according to a new report

הדמייה מ פרוייקט שער ה עיר ירושלים

Jerusalem Officials Are Setting Up a Venture Capital Fund Focused on Biotech

30.04.18|Asaf Shalev

The city is home to 150 biotech startups, a new report finds

Venture Capital Firm aMoon Aims to Raise $500 Million or More For a Second Fund

17.04.18|Lilach Baumer

Established in 2016, aMoon invests in life sciences and healthcare companies, with a focus on Israeli tech

Pontifax Raises a $240 Million Fifth Fund

01.01.18|Meir Orbach

Life sciences-focused venture capital firm Pontifax is expected to invest most of the new fund in the pharmaceutical industry

Previous Articles